Idebenone: Clinical Potential Beyond Neurological Diseases

Area of Science:

• Mitochondrial biology
• Pharmacology
• Clinical research

Background:

• Idebenone, a coenzyme Q10 analog, enhances mitochondrial function by supporting electron transport chain complex III and adenosine triphosphate production.
• While established for neurological diseases, idebenone exhibits broader therapeutic potential through mechanisms like modulating mitochondrial membrane potential and apoptosis.

Purpose of the Study:

• To comprehensively review the clinical potential of idebenone beyond its established neurological applications.
• To explore idebenone's efficacy in diverse conditions including cancers, cardiovascular diseases, diabetes, and liver diseases.

Main Methods:

• Systematic literature review of clinical trials and preclinical studies.
• Analysis of idebenone's molecular mechanisms and therapeutic outcomes in various disease models.

Main Results:

• Idebenone demonstrates promising effects in preclinical and clinical studies for various cancers (e.g., breast cancer, melanoma).
• Evidence suggests idebenone's benefits in cardiovascular diseases (e.g., atherosclerosis, heart failure), diabetes mellitus, and liver diseases.
• Mechanisms include ROS reduction, anti-lipid peroxidation, and modulation of cell death pathways.

Conclusions:

• Idebenone shows significant therapeutic promise for a wide range of non-neurological conditions.
• Further extensive clinical validation is essential to confirm idebenone's efficacy and safety in these diverse disease areas.